Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed ...

CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced a series of updates stemming from the impact ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 6, 2025. Alcon is pleased to welcome shareholders to ...

Alcon innovations featured in more than 75 abstracts across cataract, refractive, visualization and ocular health1 Clinical data presentations and sponsored symposia to highlight the efficacy of Alcon ...

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives.

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, today released its inaugural Corporate Responsibility (CR) report. The CR ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio NEW ORLEANS — Alcon introduced its ...

LumiThera’s photobiomodulation (PBM) device is the first and only technology that has demonstrated meaningful visual improvement with two years of treatments* in early and intermediate dry AMD ...